Max Robotics — Global Service Robot Directory + US Certification

About

Xuemin Li’s research bridges molecular genetics and clinical surgery, with key contributions spanning cancer predisposition gene discovery and postoperative infection control. In a landmark 2003 study, Li led the comprehensive scanning of the entire ATM gene using the DOVAM-S method, overcoming the challenges posed by its 66 exons and lack of mutational hotspots—work that has garnered 53 citations and remains foundational for ataxia-telangiectasia and cancer risk research. More recently, Li shifted focus to surgical outcomes, authoring a 2023 study identifying risk factors and phenotypes of surgical site infection (SSI) after abdominal surgery in China. This work, with 22 citations, provides critical epidemiological data on SSI incidence and clinical features, directly informing perioperative care protocols. Li’s ability to tackle complex problems—from large-gene mutation detection to real-world patient safety—demonstrates remarkable versatility. By combining rigorous molecular techniques with clinically actionable research, Li has made lasting impacts in both genomic medicine and surgical quality improvement, offering valuable insights for students and researchers in genetics, oncology, and surgery.